Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history.

(Illustration by Flora Bai for The Washington Post)

Ozempic is changing how we spend money and time, plus what we eat

 What to know

GLP-1 drugs like Ozempic and Wegovy are reshaping consumer behavior, affecting sectors like apparel, grocery and travel. According to Gallup, 12.4 percent of U.S. adults now use these drugs, leading to changes in spending habits and a drop in obesity rates. Companies are adapting by offering health-focused products and services. However, the drugs’ high cost remains a barrier for many Americans.

Summary is AI-generated, newsroom-reviewed.

Join the conversation

How do you think the rise in GLP-1 drug usage will impact the snack food industry and its approach to product development?

Have a question? Ask the Post AI to learn more